Implantable Cardiovascular Devices, Including Pacemakers, Implantable Cardioverter-defibrillators, Ventricular Assist Devices and Cardiac Loop Recorders, Are Designed to Help Manage a Person's Heart Rate or Rhythm Problems and to Control or Monitor Irregular Heartbeats in People with Certain Arrhythmias and Heart Failure, for Patients with Bradycardia, Ventricular Arrhythmias or Supraventricular Arrhythmias. It is Used in Patients with Bradycardia, Ventricular Arrhythmias or Supraventricular Arrhythmias.Implantable Cardiovascular Devices Can Help Support Cardiac Patients by Using Painless Electrical Signals to Keep the Heart Beating Regularly and Improve Function when the Device is Placed Through a Minimally Invasive Procedure. in Addition to Delivering Electrical Pulses, the Implantable Device is Now Able to Send Clinical Data Directly to the Physician Using Remote Monitoring. It Will Continuously Collect Information About the Heart Rhythm, Which is Transmitted Wirelessly to Medical Personnel when Symptoms Occur, Thus Facilitating Remote Monitoring, Which Doctors Can Use to Manage the Condition and Potentially Detect Signs of Deterioration Earlier. Not Only Do These Devices Improve Heart Disease Symptoms, but They Have Been Shown to Improve Long-term Survival Rates.These Devices Continue to Get Smaller, More Efficient, and Have Longer Battery Life. These Devices Are Usually Inserted Under Local Anesthesia and They Are Located Just Below the Collarbone to Avoid Being Visible from the Outside of the Body. Most Devices Require Periodic Monitoring, Usually Once a Year, on an Outpatient Basis.
This report aims to provide a comprehensive presentation of the global market for Implantable Cardiovascular Devices study by Market Intellix gives insights concerning the market elements influencing the market, Market scope, Market division, and overlays shadow upon the leading market players featuring the positive cutthroat scene and patterns beating the years.
Global Implantable Cardiovascular Devices Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Implantable Cardiovascular Devices Market Sales, 2017-2022, 2023-2028, (Units)
Global top five Implantable Cardiovascular Devices companies in 2021 (%)
The global Implantable Cardiovascular Devices market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Implantable Cardioverter Defibrillators Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Implantable Cardiovascular Devices include Medtronic, Abbott, Boston Scientific, AbioMed, Philips Healthcare, Biotronik Se, Angel Medical Systems, Berlin Heart and LivaNova, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
The study provides the Implantable Cardiovascular Devices manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Segmental Outline:
Global Implantable Cardiovascular Devices Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global Implantable Cardiovascular Devices Market Segment Percentages, by Type, 2021 (%)
Implantable Cardioverter Defibrillators
Implantable Pacemakers
Insertable Loop Recorders
Ventricular Assist Devices
Global Implantable Cardiovascular Devices Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global Implantable Cardiovascular Devices Market Segment Percentages, by Application, 2021 (%)
Hospital
Specialized Hospital
Others
Global Implantable Cardiovascular Devices Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global Implantable Cardiovascular Devices Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Implantable Cardiovascular Devices revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Implantable Cardiovascular Devices revenues share in global market, 2021 (%)
Key companies Implantable Cardiovascular Devices sales in global market, 2017-2022 (Estimated), (Units)
Key companies Implantable Cardiovascular Devices sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Medtronic
Abbott
Boston Scientific
AbioMed
Philips Healthcare
Biotronik Se
Angel Medical Systems
Berlin Heart
LivaNova
Shree Pacetronix
Jarvik Heart
EBR Systems
Medico SpA
This Report Addresses:
– Market Intelligence enables effective decision-making
– Market estimates and forecasts from 2022 to 2028
– Growth opportunities and trend analysis
– Segment and regional revenue forecast for market evaluation
– Competitive strategy and analysis of market segments
– List of product innovations to stay on top.
– The impact of COVID-19 and how to survive in these fast-growing markets.
1 Introduction to Research & Analysis Reports
1.1 Implantable Cardiovascular Devices Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Implantable Cardiovascular Devices Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Implantable Cardiovascular Devices Overall Market Size
2.1 Global Implantable Cardiovascular Devices Market Size: 2021 VS 2028
2.2 Global Implantable Cardiovascular Devices Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Implantable Cardiovascular Devices Sales: 2017-2028
3 Company Landscape
3.1 Top Implantable Cardiovascular Devices Players in Global Market
3.2 Top Global Implantable Cardiovascular Devices Companies Ranked by Revenue
3.3 Global Implantable Cardiovascular Devices Revenue by Companies
3.4 Global Implantable Cardiovascular Devices Sales by Companies
3.5 Global Implantable Cardiovascular Devices Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Implantable Cardiovascular Devices Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Implantable Cardiovascular Devices Product Type
3.8 Tier 1, Tier 2 and Tier 3 Implantable Cardiovascular Devices Players in Global Market
3.8.1 List of Global Tier 1 Implantable Cardiovascular Devices Companies
3.8.2 List of Global Tier 2 and Tier 3 Implantable Cardiovascular Devices Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Implantable Cardiovascular Devices Market Size Markets, 2021 & 2028
4.1.2 Implantable Cardioverter Defibrillators
4.1.3 Implantable Pacemakers
4.1.4 Insertable Loop Recorders
4.1.5 Ventricular Assist Devices
4.2 By Type - Global Implantable Cardiovascular Devices Revenue & Forecasts
4.2.1 By Type - Global Implantable Cardiovascular Devices Revenue, 2017-2022
4.2.2 By Type - Global Implantable Cardiovascular Devices Revenue, 2023-2028
4.2.3 By Type - Global Implantable Cardiovascular Devices Revenue Market Share, 2017-2028
4.3 By Type - Global Implantable Cardiovascular Devices Sales & Forecasts
4.3.1 By Type - Global Implantable Cardiovascular Devices Sales, 2017-2022
4.3.2 By Type - Global Implantable Cardiovascular Devices Sales, 2023-2028
4.3.3 By Type - Global Implantable Cardiovascular Devices Sales Market Share, 2017-2028
4.4 By Type - Global Implantable Cardiovascular Devices Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Implantable Cardiovascular Devices Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Specialized Hospital
5.1.4 Others
5.2 By Application - Global Implantable Cardiovascular Devices Revenue & Forecasts
5.2.1 By Application - Global Implantable Cardiovascular Devices Revenue, 2017-2022
5.2.2 By Application - Global Implantable Cardiovascular Devices Revenue, 2023-2028
5.2.3 By Application - Global Implantable Cardiovascular Devices Revenue Market Share, 2017-2028
5.3 By Application - Global Implantable Cardiovascular Devices Sales & Forecasts
5.3.1 By Application - Global Implantable Cardiovascular Devices Sales, 2017-2022
5.3.2 By Application - Global Implantable Cardiovascular Devices Sales, 2023-2028
5.3.3 By Application - Global Implantable Cardiovascular Devices Sales Market Share, 2017-2028
5.4 By Application - Global Implantable Cardiovascular Devices Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Implantable Cardiovascular Devices Market Size, 2021 & 2028
6.2 By Region - Global Implantable Cardiovascular Devices Revenue & Forecasts
6.2.1 By Region - Global Implantable Cardiovascular Devices Revenue, 2017-2022
6.2.2 By Region - Global Implantable Cardiovascular Devices Revenue, 2023-2028
6.2.3 By Region - Global Implantable Cardiovascular Devices Revenue Market Share, 2017-2028
6.3 By Region - Global Implantable Cardiovascular Devices Sales & Forecasts
6.3.1 By Region - Global Implantable Cardiovascular Devices Sales, 2017-2022
6.3.2 By Region - Global Implantable Cardiovascular Devices Sales, 2023-2028
6.3.3 By Region - Global Implantable Cardiovascular Devices Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Implantable Cardiovascular Devices Revenue, 2017-2028
6.4.2 By Country - North America Implantable Cardiovascular Devices Sales, 2017-2028
6.4.3 US Implantable Cardiovascular Devices Market Size, 2017-2028
6.4.4 Canada Implantable Cardiovascular Devices Market Size, 2017-2028
6.4.5 Mexico Implantable Cardiovascular Devices Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Implantable Cardiovascular Devices Revenue, 2017-2028
6.5.2 By Country - Europe Implantable Cardiovascular Devices Sales, 2017-2028
6.5.3 Germany Implantable Cardiovascular Devices Market Size, 2017-2028
6.5.4 France Implantable Cardiovascular Devices Market Size, 2017-2028
6.5.5 U.K. Implantable Cardiovascular Devices Market Size, 2017-2028
6.5.6 Italy Implantable Cardiovascular Devices Market Size, 2017-2028
6.5.7 Russia Implantable Cardiovascular Devices Market Size, 2017-2028
6.5.8 Nordic Countries Implantable Cardiovascular Devices Market Size, 2017-2028
6.5.9 Benelux Implantable Cardiovascular Devices Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Implantable Cardiovascular Devices Revenue, 2017-2028
6.6.2 By Region - Asia Implantable Cardiovascular Devices Sales, 2017-2028
6.6.3 China Implantable Cardiovascular Devices Market Size, 2017-2028
6.6.4 Japan Implantable Cardiovascular Devices Market Size, 2017-2028
6.6.5 South Korea Implantable Cardiovascular Devices Market Size, 2017-2028
6.6.6 Southeast Asia Implantable Cardiovascular Devices Market Size, 2017-2028
6.6.7 India Implantable Cardiovascular Devices Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Implantable Cardiovascular Devices Revenue, 2017-2028
6.7.2 By Country - South America Implantable Cardiovascular Devices Sales, 2017-2028
6.7.3 Brazil Implantable Cardiovascular Devices Market Size, 2017-2028
6.7.4 Argentina Implantable Cardiovascular Devices Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Implantable Cardiovascular Devices Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Implantable Cardiovascular Devices Sales, 2017-2028
6.8.3 Turkey Implantable Cardiovascular Devices Market Size, 2017-2028
6.8.4 Israel Implantable Cardiovascular Devices Market Size, 2017-2028
6.8.5 Saudi Arabia Implantable Cardiovascular Devices Market Size, 2017-2028
6.8.6 UAE Implantable Cardiovascular Devices Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Medtronic
7.1.1 Medtronic Corporate Summary
7.1.2 Medtronic Business Overview
7.1.3 Medtronic Implantable Cardiovascular Devices Major Product Offerings
7.1.4 Medtronic Implantable Cardiovascular Devices Sales and Revenue in Global (2017-2022)
7.1.5 Medtronic Key News
7.2 Abbott
7.2.1 Abbott Corporate Summary
7.2.2 Abbott Business Overview
7.2.3 Abbott Implantable Cardiovascular Devices Major Product Offerings
7.2.4 Abbott Implantable Cardiovascular Devices Sales and Revenue in Global (2017-2022)
7.2.5 Abbott Key News
7.3 Boston Scientific
7.3.1 Boston Scientific Corporate Summary
7.3.2 Boston Scientific Business Overview
7.3.3 Boston Scientific Implantable Cardiovascular Devices Major Product Offerings
7.3.4 Boston Scientific Implantable Cardiovascular Devices Sales and Revenue in Global (2017-2022)
7.3.5 Boston Scientific Key News
7.4 AbioMed
7.4.1 AbioMed Corporate Summary
7.4.2 AbioMed Business Overview
7.4.3 AbioMed Implantable Cardiovascular Devices Major Product Offerings
7.4.4 AbioMed Implantable Cardiovascular Devices Sales and Revenue in Global (2017-2022)
7.4.5 AbioMed Key News
7.5 Philips Healthcare
7.5.1 Philips Healthcare Corporate Summary
7.5.2 Philips Healthcare Business Overview
7.5.3 Philips Healthcare Implantable Cardiovascular Devices Major Product Offerings
7.5.4 Philips Healthcare Implantable Cardiovascular Devices Sales and Revenue in Global (2017-2022)
7.5.5 Philips Healthcare Key News
7.6 Biotronik Se
7.6.1 Biotronik Se Corporate Summary
7.6.2 Biotronik Se Business Overview
7.6.3 Biotronik Se Implantable Cardiovascular Devices Major Product Offerings
7.6.4 Biotronik Se Implantable Cardiovascular Devices Sales and Revenue in Global (2017-2022)
7.6.5 Biotronik Se Key News
7.7 Angel Medical Systems
7.7.1 Angel Medical Systems Corporate Summary
7.7.2 Angel Medical Systems Business Overview
7.7.3 Angel Medical Systems Implantable Cardiovascular Devices Major Product Offerings
7.7.4 Angel Medical Systems Implantable Cardiovascular Devices Sales and Revenue in Global (2017-2022)
7.7.5 Angel Medical Systems Key News
7.8 Berlin Heart
7.8.1 Berlin Heart Corporate Summary
7.8.2 Berlin Heart Business Overview
7.8.3 Berlin Heart Implantable Cardiovascular Devices Major Product Offerings
7.8.4 Berlin Heart Implantable Cardiovascular Devices Sales and Revenue in Global (2017-2022)
7.8.5 Berlin Heart Key News
7.9 LivaNova
7.9.1 LivaNova Corporate Summary
7.9.2 LivaNova Business Overview
7.9.3 LivaNova Implantable Cardiovascular Devices Major Product Offerings
7.9.4 LivaNova Implantable Cardiovascular Devices Sales and Revenue in Global (2017-2022)
7.9.5 LivaNova Key News
7.10 Shree Pacetronix
7.10.1 Shree Pacetronix Corporate Summary
7.10.2 Shree Pacetronix Business Overview
7.10.3 Shree Pacetronix Implantable Cardiovascular Devices Major Product Offerings
7.10.4 Shree Pacetronix Implantable Cardiovascular Devices Sales and Revenue in Global (2017-2022)
7.10.5 Shree Pacetronix Key News
7.11 Jarvik Heart
7.11.1 Jarvik Heart Corporate Summary
7.11.2 Jarvik Heart Implantable Cardiovascular Devices Business Overview
7.11.3 Jarvik Heart Implantable Cardiovascular Devices Major Product Offerings
7.11.4 Jarvik Heart Implantable Cardiovascular Devices Sales and Revenue in Global (2017-2022)
7.11.5 Jarvik Heart Key News
7.12 EBR Systems
7.12.1 EBR Systems Corporate Summary
7.12.2 EBR Systems Implantable Cardiovascular Devices Business Overview
7.12.3 EBR Systems Implantable Cardiovascular Devices Major Product Offerings
7.12.4 EBR Systems Implantable Cardiovascular Devices Sales and Revenue in Global (2017-2022)
7.12.5 EBR Systems Key News
7.13 Medico SpA
7.13.1 Medico SpA Corporate Summary
7.13.2 Medico SpA Implantable Cardiovascular Devices Business Overview
7.13.3 Medico SpA Implantable Cardiovascular Devices Major Product Offerings
7.13.4 Medico SpA Implantable Cardiovascular Devices Sales and Revenue in Global (2017-2022)
7.13.5 Medico SpA Key News
8 Global Implantable Cardiovascular Devices Production Capacity, Analysis
8.1 Global Implantable Cardiovascular Devices Production Capacity, 2017-2028
8.2 Implantable Cardiovascular Devices Production Capacity of Key Manufacturers in Global Market
8.3 Global Implantable Cardiovascular Devices Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Implantable Cardiovascular Devices Supply Chain Analysis
10.1 Implantable Cardiovascular Devices Industry Value Chain
10.2 Implantable Cardiovascular Devices Upstream Market
10.3 Implantable Cardiovascular Devices Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Implantable Cardiovascular Devices Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
Historical Data (2015-2019) |
|
|
Influencing Factors |
|
|
Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|